Vaccine wastage in the littoral region, Cameroon : differences between rural and urban health districts and policy implications by Nkenyi Rene Nke
 
 
저 시-비 리- 경 지 2.0 한민  
는 아래  조건  르는 경 에 한하여 게 
l  저 물  복제, 포, 전송, 전시, 공연  송할 수 습니다.  
다 과 같  조건  라야 합니다: 
l 하는,  저 물  나 포  경 ,  저 물에 적 된 허락조건
 명확하게 나타내어야 합니다.  
l 저 터  허가를 면 러한 조건들  적 되지 않습니다.  
저 에 른  리는  내 에 하여 향  지 않습니다. 




저 시. 하는 원저 를 시하여야 합니다. 
비 리. 하는  저 물  리 목적  할 수 없습니다. 
경 지. 하는  저 물  개 , 형 또는 가공할 수 없습니다. 
 
 
Vaccine Wastage in the Littoral Region, Cameroon: 
Differences Between Rural and Urban Health 








Graduate School of Public Health 
Yonsei University 
Department of Global Health Security 




Vaccine Wastage in the Littoral Region, Cameroon: 
Differences Between Rural and Urban Health 
Districts and Policy Implications 
 
Directed by: Professor Sunjoo Kang 
 
 
A Master’s Thesis 
Submitted to the Department of Global Health Security, 
Graduate School of Public Health of Yonsei University 
in partial fulfillment of the  
requirements for the degree of  
Master of Public Health 
 
Nkenyi Rene Nke 
 






I dedicate this thesis to my wife; Mrs. Sophie Nkenyi, to my children; Britney Nkenyi, 
Glaucia Nkenyi and Rhema Nkenyi and to my parents Andrew and Deborah Nkenyi, for 
providing me with unconditional love, support and continuous encouragement throughout my 
years of study and through the process of researching and writing this thesis. This 




I express my profound gratitude to KOICA-Korean Government for giving me this opportunity to 
study Global Health Security that has greatly reshaped not only my professional knowhow but 
also my attitude.  Great Thanks also go to my supervisors Prof. Sunjoo Kang of Yonsei 
University and Dr. Se Eun Park of the International Vaccine Institute (IVI), and the biostatistics 
department of IVI under the dynamic leadership of Dr Yun Chon, for their tireless efforts in 
actively guiding me through their expert supervision. In this light I want to single out Mr Gi Deok 
and colleagues for their dedicated efforts to see this project a reality.  
Special also thanks go to Prof. Myung Ken Lee and the entire team of expert lecturers in the 
Department of Global Health Security, Graduate School of Public Health, Yonsei University for 
their valuable lessons that has made it possible for me to be what I am now; a refined and 
transformed public health expert. 
Without being able to exhaust the list, I would like to express my deep appreciation to the 
following persons: Mr. and Mrs Nkenyi Aarry, Mrs Anna Mbua, Mr. Nfor Muna and my grand 
mother Mrs Awawin Esther. They supported and encourage me throughout these times. Also to 
my siblings Florencia, Jenevieve, Marceline, Etienne, Bryan, Research and Silvia, I say ‘Merci 
beaucoup’   
A special thank you is indisputably extended to Mr. Tonga Calvin of the Central Technical Group 
(CTG) of the Expanded Program of Immunization (EPI) of Cameroon. He qualifies to be a 
coauthor of this thesis.  
This acknowledgment page will be incomplete if I fail to mention my classmates. They have been 
so instrumental in the realization of this project. I say “thank you all for being there”. 
Rene Nkenyi   
i 
 
Table of Content 
 
Table of Content......................................................................................................................... i 
List of Figures .............................................................................................................................v 
List of Tables .............................................................................................................................. vi 
List of Abbreviations ................................................................................................................ vii 
Abstract ..................................................................................................................................... ix 
I. Introduction ...................................................................................................................... 1 
 Background ............................................................................................................... 1 
 Statement of the problem ........................................................................................ 4 
 Significance of the study ........................................................................................... 5 
 Research questions ................................................................................................... 5 
II. Literature Review .............................................................................................................. 7 
 Vaccination ................................................................................................................ 7 
 History of the Expanded Program of Immunization ................................................. 8 
 History of the Expanded Program of Immunization in Cameroon ............................ 8 
 EPI targeted diseases in Cameroon ........................................................................... 9 
 Vaccination implementation strategy in Cameroon ............................................... 13 
2.5.1. Routine Immunization ..................................................................................... 13 
ii 
 
2.5.2. Additional vaccination strategies .................................................................... 15 
 The EPI vaccination calendar for infants in Cameroon ........................................... 15 
 Vaccine wastage ...................................................................................................... 15 
2.7.1. Types of vaccine wastage ................................................................................ 16 
2.7.2. Wastage factor ................................................................................................ 19 
2.7.3. Factors affecting vaccine wastage .................................................................. 19 
 Relationship between vaccine wastage and immunization coverage .................... 23 
 Reducing vaccine wastage ...................................................................................... 28 
2.9.1. Changing the vial size ...................................................................................... 28 
2.9.2. Vaccine vial monitor (VVM) ............................................................................ 28 
2.9.3. Multidose vial policy ....................................................................................... 29 
2.9.4. Earliest-expiry-first-out principle .................................................................... 30 
2.9.5. Improved procurement practices ................................................................... 30 
2.9.6. Optimizing immunization session frequency with session size and vial size .. 30 
2.9.7. Prevention of freezing ..................................................................................... 30 
2.9.8. Safe immunization practices ........................................................................... 31 
2.9.9. Improved vaccine management practices ...................................................... 31 
2.9.10. Prevention of submergence of vials in water ................................................. 31 
III. Methods ...................................................................................................................... 32 
 Study design ............................................................................................................ 32 
iii 
 
 Study setting ........................................................................................................... 32 
 Study Participants ................................................................................................... 36 
3.3.1. Inclusion criteria .............................................................................................. 36 
3.3.2. Exclusion criteria ............................................................................................. 36 
 Data source and data collecting process ................................................................ 36 
 Variables and the sources of data ........................................................................... 37 
 Calculation of wastage rate and data analysis ........................................................ 40 
3.6.1. Calculation of Vaccine coverage and vaccine wastage rate ............................ 40 
3.6.2. Data analysis ................................................................................................... 40 
 Ethical considerations ............................................................................................. 41 
 Limitations of the study .......................................................................................... 41 
IV. Results ......................................................................................................................... 43 
 Relationship between immunization coverage and vaccine wastage .................... 47 
 Urbanization and effect on vaccine wastage rate .................................................. 49 
4.2.1. Urbanization and Vaccine wastage factor ...................................................... 50 
4.2.2. Vaccine categories and wastage ..................................................................... 54 
 Effect of season on vaccine wastage rate ............................................................... 55 
4.3.1. Vaccine wastage factor and seasons ............................................................... 57 
4.3.2. Vaccine categories and wastage ..................................................................... 58 
V. Discussion ........................................................................................................................ 61 
iv 
 
VI. Conclusion ................................................................................................................... 68 
VII. References ................................................................................................................... 70 
VIII. Appendix ..................................................................................................................... 79 





List of Figures 
Figure 1. Diagrammatic presentation of the various types of immunity .................................. 7 
Figure 2. Relationship between vaccine wastage and immunization coverage ...................... 24 
Figure 3. More relationship between vaccine wastage and immunization coverage ............. 25 
Figure 4. The Littoral region and the other 9 health regions of Cameroon  ........................... 33 
Figure 5. Vaccine wastage rates for various vaccines comparing 2016 and 2017 ................. 47 
Figure 6. Variations between vaccine coverage and vaccine wastage for BCG, IPV and 
Measles in 2016 ...................................................................................................................... 48 
Figure 7. Variations between vaccine coverage and vaccine wastage for BCG, IPV and 
Measles in 2017 ...................................................................................................................... 48 
Figure 8. Vaccine wastage comparing rural and urban health districts in 2016 ..................... 49 
Figure 9. Vaccine wastage comparing rural and urban health districts in 2017 ..................... 50 
Figure 10.  Comparison of vaccine wastage factor between rural and urban health districts 51 
Figure 11. Vaccine wastage between rural and urban health districts comparing 2016 and 2017 ........ 54 
Figure 12. Vaccine wastage comparing the dry and the rainy season in 2016 ....................... 55 
Figure 13. Vaccine wastage comparing the dry and the rainy season in 2017 ....................... 56 
Figure 14. Vaccine wastage comparing 2016 and 2017 between the dry and the rainy seasons .......... 56 




List of Tables 
Table 1. Targets for vaccination coverage and VWR in 2017 and Vaccination coverage in 
Cameroon for some Vaccines ................................................................................................... 4 
Table 2. EPI vaccination calendar of Cameroon from 2015 till date ..................................... 17 
Table 3. Types of vaccine wastage ......................................................................................... 18 
Table 4. Problematic time trend relationships between immunization coverage and vaccine 
wastage .................................................................................................................................... 26 
Table 5. EPI 2017 estimated population for the littoral region, Cameroon ............................ 35 
Table 6. Variables in the study ............................................................................................... 38 
Table 7. A comparison of children vaccinated and vaccine used between rural and urban 
districts as well as between dry and the rainy season ............................................................. 45 
Table 8. Wastage rate and wastage factor for different vaccines in the Littoral region in 
between 2016 and 2017 ........................................................................................................... 46 
Table 9. Vaccine wastage rates for various vaccines comparing rural and urban health districts
 ................................................................................................................................................. 52 
Table 10. Differences in vaccine rate classified into route of administration and type of 
vaccine, comparing rural and urban health settings ................................................................ 53 
Table 11. Statistical differences in vaccine wastage comparing the dry and the rainy seasons
 ................................................................................................................................................. 59 
Table 12. Differences in vaccine rate classified into route of administration and type of 





List of Abbreviations 
AFP Acute Flaccid Paralysis 
AIDS Acquired Immune Deficiency Syndrome 
ATT Ante Tetanus Toxoids 
BCG Bacillus Calmette Guérin  
CTG Central Technical Group 
DPT Diphtheria -Pertussis-Tetanus 
EPI Expanded Program on Immunization 
GAVI Global Alliance for Vaccines and Immunization 
HPV Human Papiloma Virus 
IPV Inactivated Polio Vaccine 
IVI International Vaccine Institute  
KB Koch's Bacillus 
LIC Low Income Countries 
MDVP Multi-dose Vial Policy 
MR Measles and Rubella 
MoPH Ministry of Public Health 
MOV Missed Opportunity to Vaccinate 
MPA Minimum Package of Activities 
OCEAC Organization for the Coordination of Endemic Disease Control in Central 
Africa 
OPV Oral Polio Vaccine 
OVP Open Vial Policy 
PCV Pneumococcal Conjugate Vaccine 
PENTA Diphtheria, Pertussis, Tetanus Hepatitis B and Hemophilus influenza type b 
viii 
 
PHC Primary Health Care 
RDPH Regional Delegate of Public Health 
SIAs Supplementary Immunization Activities 
TB Tuberculosis 
UN United Nations 
UNICEF The United Nations Children's Fund 
VPDs Vaccine Preventable Diseases 
VVM Vaccine vial monitor  
VWF Vaccine Wastage Factor 
VWR Vaccine Wastage Rates 




Introduction: Vaccination is a major and cost-effective public health intervention in the 
prevention of infectious diseases, especially in children. Availability of vaccine is a prerequisite 
for high vaccination coverage and vaccine wastage renders vaccines less available for use. In 
Cameroon, the Expanded Program of Immunization (EPI) vaccinates all children less than 5 years 
free of charge but the vaccination coverage has consistently remained below target.  Distribution 
of vaccines are based on the target population size and some ‘wastage norms’ but wastage rates 
may differ from locality to locality. This study seeks assess vaccine wastage rates and compare it 
between various settings in the Littoral Region of Cameroon. 
Methods: This was a record based analytical study carried out in the Littoral Region of 
Cameroon using the 2016 and 2017 immunization data. Health districts were classified as ‘urban’ 
or ‘rural’ based on their remoteness. Vaccine wastages and vaccine wastage factor were 
calculated and compared between the rainy and the dry seasons.  
Results: A total of 2851527 doses of vaccines were used to vaccinate 2640077 children during 
the two years. Vaccine wastage was highest in BCG (32.19%), then MR (19.05%) and yellow 
fever (18.34%). The single-dose vaccine vials had negative vaccine wastage rates (VWR). 
February and November always experienced a decrease in vaccination coverage and over the 
months, whenever vaccination coverage decreases VWR increases and vice versa. VWR for all 
vaccines were higher during the dry season, except in 2016, where the VWR for lyophilized 
vaccine were higher in the rainy season. VWR were continuously higher in the rural districts.  
Conclusion: Vaccine wastage greatly differs between rural and urban health districts but also 
between the dry and the rainy season with most of the wastage occurring in the rural districts and 
surprisingly during the dry season where climatic conditions are more favourable. 






A number of ways exist to protect children as they grow up, some of which include, 
proper dressing, proper positioning of electrical appliances in the house and the use of seat 
belts in vehicles. However, when it comes to protection against childhood diseases, the 
medical community strongly recommends vaccination(1,2). Vaccines are second only to safe 
water in reducing mortality and not even antibiotics has had such an effect on morbidity and 
mortality(2,3).  
Worldwide, vaccines are available to prevent many diseases in people of all ages(4). 
For childhood diseases, the primary vaccine preventable diseases (VPDs) for which vaccines 
are readily available are diphtheria, invasive diseases caused by the Haemophilus influenza 
type b (Hib) bacterium, measles, poliomyelitis (polio), rubella (“German” measles), 
tuberculosis (TB), tetanus, mumps, varicella (chickenpox), pertussis (whooping cough) 
pneumococcal infections, and diarrhea with rotavirus(3,4).  
Although infectious diseases is not only a thing of the developing countries, the 
situation is much worse in there where VPDs cause more than 10 million DALYs and 
vaccination coverage still remains uncomfortably low(5–7) despite knowledge of the fact that 
vaccination not only protects individuals but also limits the spread of disease in the general 
population(2). Efforts to improve quality vaccination coverage and timeliness are very much 
needed in low income countries where within a the countries, vaccination coverage differs 




Availability of vaccines and vaccine products are some of the very important factors 
that influence vaccination coverage and this is critical in low income countries (LIC) (8,9). 
With the relatively high frequency of the introduction of new vaccines in recent years, 
importance is laid on vaccine management since new vaccines are more expensive (8,10,11). 
Effective and efficient management and utilization enhances regular supply of the vaccines 
and this is essential to ensure vaccine security while simultaneously keeping a check on 
program costs(12). To increase vaccination coverage, there is a strong recommendation to 
reduce missed opportunity to vaccinate (MOV)(13). Though vaccination coverage is never to 
be compromised by considering the cost of the vaccine, the recommendations to reduce 
MOV may sometimes conflict with recommendations to reduce vaccine wastage(8) 
especially if the policy is not clearly transmitted to the health personnel involved in 
vaccination. 
WHO points to a worldwide statistic of more than 50% vaccine wastage(9,14,15). In 
1997, WHO officially stated that 43% of vaccines delivered to developing countries don’t 
end up being administer to children caused mainly by poor infrastructure(16). National 
statistics being it immunization coverage or wastage usually cover rural-urban 
differences(17) which is inextricably linked to difference in field realities (infrastructure). 
While urban areas face its own difficulties in vaccination activities which are mostly linked 
to low quality of monitoring and tracking(18), factors such as parent’s objection or 
disagreement, concerns about safety of vaccines, walking distances to health facilities and 
waiting time in the health facilities, health worker density and logistics availability are 
usually more prevalent in rural than urban settings(19,20) and plays some role in vaccine 
wastage. Also, the dispersed nature of the population and the long distances to travel by a 
health worker on an outreach vaccination session coupled with poor road network may 
compromise the cold chain leading to vaccine wastage. In small facilities; typically in rural 
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areas, vaccine wastage rate may be high compared to large hospitals typically in urban 
areas(21). Therefore vaccine wastage is related to vaccine handling and utilization(22) which 
differs between urban and rural areas due to differences in field realities. With generally low 
immunization coverage in rural areas(23), it can be suspected that there is link with high 
vaccine wastage or it can lead to high vaccine wastage. 
In Cameroon, the Expanded Program on Immunization (EPI) began in 1976 as a 
coordinated pilot project of the Organization for the Coordination of Endemic Disease 
Control in Central Africa (OCEAC). This pilot project became an operational program 
throughout the country in 1982(4). The EPI aims to prevent, control, eliminate or eradicate 
VPDs. Following the Declaration of the Reorientation of Primary Health Care in 1993, EPI 
activities were integrated into the Minimum Package of Activities (MPA) of health facilities 
nationwide(4) and are given to children free of charge, where vaccination is seen as a 
fundamental right of every child.  
Cameroon’s health system is made up of 10 regions and 189 health districts(24) and 
among the 10 regions is the Littoral Region which is one of the most densely populated with 
24 health districts. This region significantly influences the national immunization statistics. 
Out of the 24 health Districts, 3 are urban, 9 are semi-urban and 12 are rural health districts, 
with the semi-rural districts lacking the typical criteria of the rural districts.  
There are two seasons in Cameroon; the rainy and the dry season. The former usually 
beginning from June and ending in November(25) has more consequential effects on 
immunization activities and vaccine supply chain especially in rural areas as road networks 
are usually despicably poor couple with rampant power failure. These can lead to both open 
and unopened vial vaccine wastage.  
Though there has been improvements over the years, immunization coverage in 
Cameroon still falls short of target (Table 1a) with many eligible children going unvaccinated 
or incompletely vaccinated even in central cities(26) and these may be due to programmatic 
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errors in terms of vaccine logistics(27). Not only is the government aiming at high 
vaccination coverage, it is also aiming to keep vaccine wastage in check. For instance, Table 
1b shows the vaccination coverages and vaccine wastage rates (VWR) targeted in 2017 in 
Cameroon(28) compared with WHO projected acceptable wastage rates(29). 
 
 
 Statement of the problem 
Immunization coverage is unquestionably related to vaccine wastage because wastage 
translate to less vaccines available for use especially in areas of poor accessibility to vaccine 
storage facility(8,9). However, vaccine wastage cannot be completely avoided and so must be 
incorporated in calculating the vaccine need of a population. Cameroon government views 
vaccination as a fundamental right of every child and to this regard, has consistently been 
seeking to improving vaccination coverage over the years but they still fall below target. 
Seeking to improve immunization coverage goes with seeking to reduce vaccine wastage 
which differ between rural and urban settings, depending on field realities. Such differences 
 
Antigen 
Vaccination coverage (%) 
2015 2016 2017 
BGC 74 70 91 
PENTA 1 92 92 93 
PENTA 3 84 85 86 
OPV3 83 83 84 













BCG 89 25 50 
VPO 89 10 10 
VPI 79 10 15 
Penta 89 6 15 
PCV 89 3 5 
ROTA 82 5 5 
MM 89 25 25 




Table 1. Targets for vaccination coverage and VWR in 2017 and Vaccination coverage in 
Cameroon for some Vaccines 
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need to be monitored continuously and used in calculating vaccine needs of a population 
otherwise it may lead to irrational or inappropriate distribution of vaccines, which can further 
potentiate vaccine wastage. Very few studies on vaccine wastage has been conducted in 
Cameroon and none sort to estimate vaccine wastage variations between different 
environmental and climatic conditions.   
 Significance of the study 
High immunization courage unquestionably depends on adequate supply of vaccines 
which is calculated taking into account vaccine wastage. Because vaccines are costly, 
wastage should therefore be reduced as much as possible (without compromising vaccination 
coverage) since it cannot be completely avoided. Various factors influence vaccine wastage 
some of which are much more prevalent in certain localities than others necessitating 
continuous monitory of vaccine wastage and its use in the estimation of the vaccine needs of 
such localities. 
The Littoral region of Cameroon just like many other regions in the country has been 
having challenges to meeting immunization targets over the years and to meet these targets, 
adequate supply of vaccines is a prerequisite. Vaccines are distributed from the central level 
to the peripheral level based on estimated administrative target population, wastage norms, 
coverage objective and some security margin. This top-down distribution of vaccines may 
lead to inappropriate distribution of vaccines hence worsening vaccine wastage and it effect 
on coverage and efficiency of the program. In the littoral region where population mobility is 
high, mastery of the target population by the central level is difficult and slight increase in 
wastage rate above national norms may increase the risk of vaccine stock out. This calls for 
the need for local vaccine rates to be mastered and continuously monitored. 
 Research questions 
Vaccine wastage cannot be completely avoided and therefore must be incorporated in 
vaccine needs of the population. Also, vaccines especially newer vaccines are costly and 
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wastage increases the cost of the program and should be reduced as much as possible. To 
better understand whether vaccine wastage is high enough, it should be analyzed together 
with vaccination coverage rate and pattern of vaccine wastage should be compared with that 
of vaccination coverage. This study seeks therefore to answer the question: ‘what is the 
relationship between immunization coverage and vaccine wastage?’ 
The health system in the rural areas are different from those in that urban areas in 
terms of infrastructure and personnel among others. Also, the characteristics of the 
population structure in the rural area is different from that in the urban area. For example, 
rural population are likely to be made up of less educated person compared to the urban 
population and vaccine take up in a less educated population is low(30)  Again, the nature of 
the terrain in urban areas is made more accessible than the terrain in rural areas facilitating 
the transportation of vaccines and vaccine products. With these differences, it is important to 
know if vaccine wastage differ between rural areas and in urban areas. 
There are two main seasons in the Littoral region of Cameroon; the rainy and the dry 
season. The rainy season beginning from June and ending in November has more devastating 
effects as the road networks become very poor, electricity failure is almost constant and the 
rains may render some vaccination seasons impossible to be attended the population. These 
challenging circumstances may have an effect on vaccine wastage. Therefore, this study 
seeks also to find out if there are any differences in vaccine wastage between the rainy and 




II. Literature Review 
 
 Vaccination 
Vaccination is the artificial introduction of a pathogen-based product into the body of a 
healthy individual or a patient.  This product must be able to induce in the recipient specific 
antibodies against the development of the pathogen. As one of the best efficient preventive 
measures, vaccination is in line with Primary Health Care (PHC) activities whose aim is the 
promotion of the health of individuals and communities. 
While vaccination is sometimes used interchangeably with immunization, immunity is 
actually an organism’s ability to defend itself when attacked by a pathogenic agent. 
Immunization therefore refers to all humoral and cellular factors that protect the body against 
any form of attack. It confers immunity either by antigen being introduced in to the body 
(active) or by the introduction of specific antibodies (passive). There are two types of 
immunity; natural and artificial immunities as shown in the Figure 1(4). 
 








 History of the Expanded Program of Immunization 
EPI is a World Health Organization’s initiative with the goal of making vaccines 
available to all children throughout the world(31). It was initiated in May 1974 with the 
objective of vaccinating all the children of the world. Ten years later, a standardized 
scheduled was provided for some vaccines as: diphtheria-tetanus-pertussis (DPT), BCG, 
measles and oral polio vaccine (OPV)(31). As knowledge on immunologic factors of disease 
increase, some other vaccines were included into the list of EPI targeted diseases. These 
vaccines include : Hepatitis B (HepB), yellow fever for endemic countries for the disease, 
and Haemophilus influenzae meningitis (Hib) conjugate vaccine in high disease-burden 
countries. 
The Global Alliance for Vaccines and Immunization (GAVI) was created in 1999 with 
the sole objective of improving child health in very poor countries by extending the activities 
of EPI. GAVI brought together United Nations (UN) agencies and institutions (WHO, 
UNICEF, the World Bank), public health institutes, donors, like the Bill and Melinda Gates 
Foundation and, the vaccine industry, non-governmental organizations (NGOs) and many 
others. GAVI has assisted in renewing interest and maintaining the importance of 
immunizations in fighting the world’s exorbitant burden of infectious diseases(32). 
 History of the Expanded Program of Immunization in Cameroon 
In Cameroon, EPI started two years after the initiation by WHO, that is in 1976. It 
started as a pilot project that was coordinated by the Organization for the Coordination of the 
Control of Endemic Diseases in Central Africa (OCEAC). This pilot became operational in 




 EPI targeted diseases in Cameroon 
EPI programs differ from country to country with respect to the diseases they target. 
Countries especially those of the developing world do not purchase all the vaccines as soon 
as there are licensed(33) because diseases endemicity and burden differ from country to 
country. The following diseases are targeted by the EPI program(4): 
i. Tuberculosis 
TB is a contagious disease caused by Mycobacterium tuberculosis or Koch Bacillus 
(KB). It is transmitted through respiratory droplets coughed out by a person whose sputum 
contains the bacteria. The first contact with the KB (primo infection) may be unnoticed; 
however, in one out of ten cases, a primo infection may result to a full-blown disease 
(pulmonary or extra pulmonary disease). Malnutrition, alcoholism, diabetes and especially 
Acquired Immune Deficiency Syndrome (AIDS) are current risk factors. Vaccination with 
BCG remains the best means of preventing children from serious forms of TB improved 
hygiene conditions are also important(4).  
ii. Diphtheria 
This disease, caused by Corynebacterium diphtheria is an infectious one that is 
transmitted from one person to another by close personal contact or by inhalation. 
With man as the main reservoir, the incubation period is between 3 and 5 days and 
even more. Unvaccinated Children under 15 years are the most affected. Diphtheria has as 
symptoms the following: fever, running nose and sore throat. The tonsils are swollen, 
covered with greyish membrane, which can invade the vocal cords and the trachea; this can 
easily lead to suffocation. The diphtheria toxin can cause heart and kidney problems. 





This disease is as a result of the actions of neurotoxin secreted by an anaerobic 
bacterium called Clostridium tetanii which develops in soiled necrotic tissues (soiled wound, 
umbilical cord if delivery took place under poor hygiene conditions). Spores of this 
bacterium can also enter someone through open wounds as a result of farm work, 
circumcisions and scarifications. 
The incubation period of the bacterium is between 3-10 days and may go up to 3 
weeks. Symptoms usually appear before 14 days after contact. In a neonate, the newborn that 
was normal during the first few days of life becomes unable to suck due to jaw spasms and 
the spasms become generalized throughout the whole body. Neonatal tetanus is fatal in 100% 
of the cases and prevention is by immunizing infants, pregnant woman and access to good 
quality antenatal and delivery services(4,34).  
iv. Pertussis 
Pertussis, also called whooping cough is a tracheobronchial infection caused by the 
bacteria called Bordetella pertussis. Transmission is by droplet spread from an infected to 
and uninfected person. The most vulnerable groups include infants and children living in 
overcrowded environment. Man is the reservoir of the disease. 
The incubation period can go up to 21 days and the characteristic symptom is 
persistent cough for 4 to 8 weeks with characteristic whooping spasms (coughing fits) that is 
accompanied usually by cyanosis and vomiting. Apnea and death can result from the 
coughing fits in infants. Malnutrition, pneumonia, and convulsions can complicate pertussis. 





Polio is an acute viral infection caused by three types of polio viruses; type 1,2 and 3. 
In poor countries, the feocal-oral transmission is the route of importance though there exist 
the oro-pharyngeal transmission(35). 
The incubation period varies from 3 to 35 days and diagnosis is by laboratory 
examination of stool. Most cases are asymptomatic and the most common symptoms are fever, 
Acute Flaccid Paralysis (AFP) and the most effective means of prevention is through 
vaccination with the OPV and then environmental and personal hygiene(4,35).  
vi. Measles Mumps and Rubella  
This are acute viral infection that are transmitted by the respiratory route. The only 
reservoir for the disease is man and closed contact with each other is a favorable environment 
for the transmission of the disease. The patient is contagious for 2 days before the rash and 4 
days after the rash he is still contagious. There are primarily prevented by vaccination with 
the measle, Mumps and Rubella vaccine at 9 months of age 
vii. Viral hepatitis B 
This is a viral disease caused by the hepatitis B virus. Transmission is through 
unprotected sexual intercourse with an infected person. Also contact with blood of an 
infected person is a serious risk factor. Mother to child transmission is possible and during 
childhood, scratches and wound in infected children predisposes the others to the disease. A 
dangerous aspect of the disease is that infected persons may remain contagious for a very 
long time hence exposing those around them(4). The incubation period can be six weeks but 
can go up to 6 months. Signs and symptoms include: fever, jaundice, fatigue, dark urine and 
pale stools. Preventive measures include vaccination, practice of safe sex and health 
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personnel are particularly at risk since they can easily get in contact with patients’ blood if 
universal precautions are not being practiced.  
viii. Yellow fever 
This is a viral hemorrhagic fever that is transmitted from one person to another by the 
bite of a mosquito called Aedes Egypti. This mosquito breeds in stagnant waters around the 
environment. In bush areas, the monkey is the main host and man is just an accidental host 
while in urban settings, man become the main host. 
ix. Diseases caused by Hib 
The Heamophilus influenza type b bacterium causes many infections affecting mostly 
children under five years of age. There are about 6 serotype of the bacterium and the type b is 
responsible for a majority (about 80%) of severe infections in children. This bacterium is 
transmitted through respiratory droplets. That is through sneezing or coughing and the risk of 
transmission increases when children spend long times together like in overcrowding 
situations. Children less than 6 years are the most affected with the peak of vulnerability as 
from 4-12 months. Also, having a short incubation period, the symptoms of the diseases are 
as follows: fever, vomiting, lethargy, inflammation of the meninges, epiglottitis and 
obstructive laryngitis. Coma can result. Effective preventive measure lies in vaccinating the 
children(4). 
x. Pneumococcal infections  
These infections are caused by the bacterium Streptococcus pneumoniae and the most 
severe diseases are pneumonia, meningitis, and febrile bacteremia. The most common forms 
of the infections are: otitis, sinusitis and bronchitis. The incubation period is less than 5 days 
and the symptoms of the diseases are sudden onset of fever, cough, dyspnea, chills and 
sometimes chest pain. These infections can only be effectively prevented by vaccination.  
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xi. Diarrhoea with rotavirus 
This is an acute febrile gastroenteritis caused by a virus of the family rotavirus. Since it 
is highly contagious, these rotaviruses are associated most of the diarrhea in children. 
Transmission of the disease is by the faeco-oral route and an infected child is able to transmit 
the disease to others 4-5 days before becoming symptomatic and then up to 2 weeks after 
treatment.   
xii. Meningococcal infections 
Meningococcal diseases are diseases caused by the bacterium Neisseria meningitidis. 
Direct contact with the nasopharyngeal secretions of an infected person exposes the healthy 
individual to these diseases.  
This bacterium has a short incubation period that is usually less than four days. Some 
of the symptoms include: fever, headache, stiff neck, nausea, vomiting, photophobia 
convulsions, swollen fontanel drowsiness, confusion and sometimes irritability. Prevention is 
solely by vaccination with the Pneumo vaccine and avoidance of contact with infected 
individuals. 
 Vaccination implementation strategy in Cameroon 
The Ministry of Public Health (MoPH) of Cameroon stipulates that vaccines for 
routine vaccination be delivered using the following strategies: 
2.5.1. Routine Immunization  
2.5.1.1. Fixed post strategy 
These are vaccination sessions held at the health facility according to a pre-established 
program for the target group (children 0-11 months and pregnant women). This is meant for 
those persons living near the health facility (one hour’s walking distance) or who have easy 
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access to the health centers. Vaccine wastage in this strategy is usually lower than in the other 
strategies(36) since there are limited chances of accidents leading to spillage. In the littoral 
region, this strategy is most effective in urban and semi-urban districts where access to the 
health facility is easy and within walkable distance to many households. 
2.5.1.2. Outreach strategy 
These are vaccination sessions held outside a functional health facility for a portion of 
the population that is far off (more than 5km radius or beyond an hour walking distance) or 
whose geographical access to the health facility is difficult. Here the health worker displaces 
himself and vaccines on an automobile (usually motorbike) to the communities to meet the 
population. This is what is practiced in the rural districts because the population is highly 
dispersed. 
2.5.1.3. Mobile strategy 
This strategy consists in spending several days in one or more far away communities 
(usually more than 15km radius from the health facility) to carry out vaccination and other 
health activities. It is also most often (if not always) practices in rural communities. 
2.5.1.4. Vaccination in a temporary fixed post 
Vaccination in a temporary fixed post consists of installing a vaccination post in the 
community (school, station, market, etc.) for a fixed period of time. It brings the community 






2.5.2. Additional vaccination strategies 
2.5.2.1. Door to door 
Here, vaccinators travel to households to administer vaccines to children of the 
targeted group. This is done most often during Supplementary Immunization activities (SIAs) 
2.5.2.2. Special Vaccination Strategies 
Special vaccination strategies are used during SIAs. Among these sessions, the most 
frequently used are: hit and run, permanent health team, fire walling, vaccination in train 
stations, toll stations, markets, churches, fields, borders. These sessions aim to ensure access 
to vaccines for the entire target population. Hit and run, permanent health team and the fire 
walling are strategies that help to reach people living in insecure areas(4). 
 
 The EPI vaccination calendar for infants in Cameroon 
The objective of the vaccination schedule is to administer all the vaccines against EPI 
targeted diseases in five contacts before the age of one year, while respecting the time 
intervals between doses. A child is considered to be completely and correctly vaccinated 
when he or she receives all the antigens while respecting the intervals between doses, the 
routes of administration and the norms of quality vaccination(4). This is indicated in the 
vaccination calendar presented in Table 2. 
 
 Vaccine wastage 
Since wastage is the action or process of losing or destroying something by using it 
carelessly or extravagantly(37), vaccine wastage can be defined as the proportion of vaccine 
that are used but not administer considering that vaccines are designed to be administered to 




2.7.1. Types of vaccine wastage 
A vaccine dose is considered wasted if it not used to vaccinate an eligible 
person(15,16) and for these reason global guidelines for reducing vaccine wastage stipulate 
that some vaccines be used for up to 28 days {Multi-dose Vial Policy (MDVP) or Open Vial 
Policy (OVP)}. For some vaccines like the Bacillus Calmette Guérin  (BCG), Measles and 
Yellow fever vaccines, their utility is limited to 6 hours after reconstitution, after which there 
must be discarded(15,38,39). This is considered as unavoidable wastage. There are also 
avoidable vaccine wastage which include expiration, vial breakage, inappropriate vial 
freezing, theft, exposure to heat and non-respect of the OVP(15). Vaccine wastage can also 













BCG Intrademic 0.05ml Upper 1/3 of the left forearm 
OPV0 Oral  2 drops In the mouth 
6 weeks 
DPT-HepB1+Hib1 Intramuscular 0.5ml Left thigh  
OPV-1 Oral  2 drops In the mouth 
PCV13-1 Intramuscular 0.5mls Right thigh  
Rota 1 Oral 1 ampoule  In the mouth 
10 weeks 
DPT-HepB1+Hib2 Intramuscular 0.5ml Left thigh  
OPV-2 Oral 2 drops In the mouth 
PCV13-2 Intramuscular 0.5mls Right thigh  
Rota 2 Oral 1 ampoule  In the mouth 
14 weeks 
DPT-HepB1+Hib3 Intramuscular 0.5ml Left thigh  
OPV-3 Oral  2 drops In the mouth 
PCV13-3 Intramuscular 0.5mls Right thigh  
IPV Intramuscular 0.5mls Right thigh 
6-11 months Vitamin A Oral  100,000 IU In the mouth  
9 months 
MMR Subcutaneous  0.05 Left deltoid 
Yellow fever vaccine Subcutaneous  0.05 Right deltoid 
12 – 59 
months 
Vitamin A 
(every 6 months) 
Oral  200,000IU In the mouth 
Table legend: Content of the table reconstructed based on the Cameroon MOH 
guideline, 2018(4)  
Unopened vial vaccine wastage is largely linked to supply chain problems(19) where 
vaccines are wasted in intact vials  while opened vial vaccine wastage is linked to both 
18 
 
supply chain and immunization problems(4) and all needs to be monitored to help influence 
response policies(27,40).  Table 3 summarizes the differences between opened and unopened 
vial wastages.  
The reaction of a baby to immunization may also cause the dose administered to be 
wasted, especially in the case of oral vaccines where crying and agitations can cause some 
doses to be drop out of the mouth. In this circumstance, more than one dose is required to 
immunize a child. Vaccine wastage must be calculated at all levels on a routine and regular 
basis(15) However, in the absence of locality specific wastage rate, WHO provides some 
indicative wastage rates that can be used to estimate vaccine needs of a population(41). These 
rates depend on the vaccine type and the number of doses per vial.  
 
Table 3. Types of vaccine wastage 
Vaccine wastage in unopened vials Vaccine wastage in opened vials 
Expiry 
In addition to the types listed in the previous 
column: 
VVM indication Discarding remaining doses at end of session 
Heat exposure 
Not being able to draw the number of doses 
indicated on the label of a vial 
Freezing Poor reconstitution practices 
Breakage Submergence of opened vials in water 
Missing inventory Suspected contamination 
Theft Patient reaction requiring more than one dose 
Discarding unused vials returned from 
an outreach session   
Table legend: Content of the table from WHO and UNICEF, 2005 (15) 
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Since vaccine wastage cannot be completely avoided, acceptable wastage levels vary 
between programs in the light of experience and the analysis of local situations. For example, 
because of sparse population distribution, services in remote areas may have to open more 
vials than urban services to vaccinate children, and this results to higher wastage rates in rural 
areas. Similarly, in locations where a great majority of the population can only be reached 
through outreach services, higher wastage rates are expected(15,42).  
The type of vaccine wastage is important to know. A high wastage rate that is 
attributed to opening a multidose vial for a small session to avoid missed opportunities to 
vaccinate is better accepted than wastage attributed inappropriate vaccine storage. However, 
vaccine wastage is expected with lyophilized vaccines as they must be discarded within six 
hours of opening, compared to liquid vaccines that can be used in next sessions for up to 4 
weeks. 
 
2.7.2. Wastage factor 
In forecasting vaccine, the vaccine wastage factor is used instead of the vaccine 
wastage rate. The vaccine wastage factor indicates how much additional vaccine should be 
ordered in order to allow for a given wastage rate. The vaccine wastage factor (VWF) is a 
function of a vaccine wastage rate. It used is to estimate the quantity of vaccine needed in the 
locality considering the quantity that will be wasted. It varies greatly according many 
characteristics including presentation of vaccine, size of the vaccination session and supply 
management(41). Therefore, each program is encouraged to monitor its own wastage level in 
other to better calculate the VWF.  
 
2.7.3. Factors affecting vaccine wastage 
According to WHO(15), Many factors contribute to vaccine wastage, ranging from the 
vaccine to the vaccinator. They are not independent of each other: 
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2.7.3.1. Factors related to vaccines and syringes 
a) Vial size 
More wastage is reported with the larger vial sizes unless they are used in mass 
immunization activities. Different vial sizes allow immunization managers to choose the best 
presentation for the purposes of specific programs. Smaller vials cost more than larger ones 
containing the same vaccine, resulting in a higher cost per child immunized. Also, smaller 
vials require greater cold chain and vaccine transportation capacity than larger ones(43). 
a) Dead space in the syringe  
A dead space in a syringe is the space occupied by a fluid in the syringe that cannot be 
expelled. Therefore, the higher the dead space of a syringe, the higher the wastage rate since 
the same quantity of vaccine that cannot be expelled will be drawn into the syringe and not 
used to vaccinate a target. Related to dead space in the actual number of doses in a vaccine 
vial. Some vaccines are reported to have fewer doses than is indicated by the 
manufacturer(44).  
 
2.7.3.2. Factors related to national policy 
a) Supply policy 
Inaccurate vaccine forecasting may give rise to increased vaccine wastage. Health 
districts may receive more vaccines than are needed monthly, leading to the expiry of 
vaccines before they can be used. Or if their cold chain in not well adapted to keep these 
vaccines, it may get bad before it can be used. 
b) Vaccine vial monitor (VVM) introduction 
VVMs were first used with OPV during 1996. They have now been delivered with 
more than 1.5 billion doses of OPV to more than 80 countries. As from 2001, VVMs were 
included as product specifications by UNICEF for all EPI vaccines. Global Alliance for 
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Vaccines and Immunization (GAVI) also requires the use of VVMs with vaccines. To be able 
to properly use VVMs, health workers must be trained in good time. A failure to identify 
health workers who need refresher training on VVM use may also result in the incorrect use 
of VVMs and some increase in vaccine wastage. 
 
c) Discarding of doses remaining in opened vials at end of day 
Countries that are still to adopt MDVP have greater wastage rates for liquid vaccines 
than those that have adopted it already. However, where sterilizable syringes are used or 
other sources of contamination of opened vials are not under control, countries may have 
difficulties in adopting MDVP nationwide. 
 
2.7.3.3. Factors related to logistics 
a) Stock control 
adequate stock control practices require that vital information on vaccines be recorded 
when they are received, during storage and when they are leaving the store for distribution. 
Expiry dates must be recorded properly and properly followed up else, storekeepers may 
dispatch a batch that expires later than the ones kept at the store. 
b) Alternative cold chain 
An alternative cold chain, may be of value in having excess vaccine for whatever 
reason. In the case of non-availability, a pushdown distribution approach mostly results in 
vaccines from the primary vaccine store being sent to the intermediate stores and therefore to 
immunization points without checking as to whether the cold chain capacity in those areas 
can really absorb them. This puts the vaccines at risk of expiry or of being exposed to 
improper temperatures because of a lack of adequate storage capacity.  
c) Quality and management of cold chain 
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Cold chain equipment should be compatible with WHO–UNICEF product information 
sheets (PIS) else it may not be able to ensure the storage temperatures required for different 
types of vaccines. 
d) Temperature monitoring 
If the temperature in cold chain equipment for storing vaccines is not monitored and 
controlled regularly, vaccines may be at risk of exposure to unacceptable temperatures, 
resulting in wastage 
e) Vaccine distribution and transportation practices 
Vaccines are at risk of being damaged by excessive heat or freezing temperatures if 
correct practices are not followed during transportation. When this happens, there is 
increased vaccine wastage and supplies may become inadequate. 
f) Reading and/or using VVM status 
Storekeepers should know how to read and interpret VVMs and make inform choices 
before distributing vaccines. If they do not know, they may put vaccines at risk. For Instance, 
if vials with VVMs showing low heat exposure are sent to the field before vaccine vials with 
VVMs approaching the discard point, the vaccines kept behind in the store may be at risk of 
reaching their discard point still in the storage facility. 
g) Communication and supervision 
In cases where global policies to reduce vaccine wastage are adopted at national level, 
good communication down to sub national and service levels and effective supervision are 
needed to ensure that the policies are translated into local action. A lack of effective 





2.7.3.4. Factors related to immunization practice 
a) Liquid vaccines discarded at end of session (or before four weeks) 
If multidose vials of liquid vaccine presentations are not kept for subsequent sessions 
(up to four weeks) and are thrown away at the end of a session, vaccine wastage rates are 
reported to be high 
b) Reconstitution practices 
If the whole content of diluent is not used to reconstitute powder vaccine, fewer doses 
are available in the vaccine vial for vaccination. 
c) Cold chain failures 
Cold chain failures may expose vaccines to high temperatures if storekeepers and/or 
health workers do not know what to do in such cases. 
d) Session size 
If larger dose presentations are used during small session size, wastage may increase. 
The golden rule should be to avoid compromising vaccination coverage. However, tackling 
the problem with small session size can differ between outreach activities and fixed-site 
immunization points. 
e) Injection practices (contamination) 
Poor injection practices may contaminate vaccine vials. Submerging opened multidose 
vials in water makes them contaminated by default and must be discarded. If crushed ice or 
ice cubes are used in vaccine carriers during transportation of vaccines, submerging 
frequently occurs. 
 
 Relationship between vaccine wastage and immunization coverage 
WHO (15) analyses various relationships between vaccine wastage rate and 
immunization coverage and says it is key to deciding whether wastage is really high. Both 
should be analyzed over a period of time rather than at a given point in time in order to reveal 
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trends. Figure 2 indicate possible reasons for different trends in vaccine wastage and 
immunization coverage rates. 
If immunization coverage and vaccine wastage rates follow the same trend (with little 
fluctuation) in a given period (as shown in Figure 2a) it is essential to know the reasons for 
the trend in order to understand whether wastage can be reduced. Reports of the same vaccine 
wastage without any change in immunization coverage often indicate that wastage is not fully 
understood and analyzed. 
If vaccine wastage increases at a certain point over a period of time while the 
immunization coverage rate remains the same, potential causes such as expiry or cold chain 
failure during storage and transportation can be the cause (Fig. 2b). Although most wastage 
can be expected in unopened vials, discards may involve both opened and unopened vials. 
The fact that immunization coverage remains level indicates that, despite increased wastage, 
the program has had enough vaccines to replace these losses. This may indicate a need to 
review the vaccine forecast. This will determine if more vaccine than necessary is being 
ordered and received. 
 
Figure 2. Relationship between vaccine wastage and immunization coverage 
 2a 2b 
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If vaccine coverage remains the same as wastage decreases (Figure 3a), it could be 
problem with data management. Therefore, validity of data should be investigated and as well 
as the reasons for the fall in the wastage rate. It could be an improvement in the effectiveness 
of vaccine management that is responsible for the decrease in vaccine wastage. In this case, it 
should be documented and attention should then be concentrated on improving coverage 
rates. 
If the immunization coverage rate decreases and the vaccine wastage rate increases 
(Figure 3b), this indicates vaccine damage in unopened vials, resulting in losses where the 
system cannot replace the vaccine. Consequently, planned immunizations cannot be 
achieved. The problem is most likely to be at the storage level and/or during vaccine 
transportation. Depending on the type of vaccine, freezing or heat exposure of a bulk quantity 




Figure 3. More relationship between vaccine wastage and immunization coverage 
 




If both rates are decreasing the most likely reason is that the number of immunization 
sessions has been reduced, resulting in refusals to immunize children attending on non-
session days and in missed opportunities. Reducing the number of outreach activities may 
have the same effect. No matter what the reasons, the situation must be studied in detail in 
order to understand whether the approach to reducing vaccine wastage causes a similar 
decrease in immunization coverage. If a successful initiative to reduce vaccine wastage result 
in a reduction in immunization coverage, it should be reviewed. The relationships between 
immunization coverage and vaccine wastage are summarized in Table 4. 
 






Possible solution  
Same Same 
Types of vaccine wastage should be analyzed in order to 
determine whether new tools could be introduced to reduce 
wastage 
Same Increasing 
Focus on the storage and transportation of vaccines, because 
increasing wastage while coverage remains the same indicates 
wastage in unopened vials. 
If the increase is too high, vaccine forecasts should be 








Possible solution  
Same Decreasing 
Validation of the data is the first step. Since wastage is 
decreasing, special attention should be given to determining 
how to increase immunization coverage. 
Decreasing Increasing 
Vaccine damage occurs in unopened vials. Consequently, 
losses occur where the system cannot replace the vaccines and 
therefore planned immunizations cannot be achieved. The 
problem is likely to be found at the storage level and/or during 
vaccine transportation (either freezing or heat damage). The 
first step in analyzing the data should be to rule out expiry 
discards. 
Decreasing Decreasing 
The possibility has to be considered that measures used to 
reduce wastage contribute to decreased immunization 
coverage. Likely reasons are a reduced number of 
immunization sessions and a refusal to give immunization 
where this would require multidose vials to be opened, in 
order to prevent high wastage. 
Increasing Increasing 
This circumstance may arise because of increased outreach 
activity. The implementation of the multidose vial policy 







Possible solution  
during outreach activities should be examined in order to 
determine whether vaccine wastage can be reduced. 
Table legend: Content of the table from WHO and UNICEF, 2005 (15) 
 Reducing vaccine wastage  
There is no panacea for reducing vaccine wastage. A method may become more 
effective in reducing wastage if combined with other appropriate methods. Whatever method 
is used, there is only one output indicator that should not be affected negatively: vaccination 
coverage. 
2.9.1. Changing the vial size 
The use of smaller vaccine vials sizes (presentation) naturally results in less vaccine 
wastage. However, the decision to change the vial size for smaller ones is not easy, as it 
needs to take into consideration many other factors. Some of these factors include, price and 
volume of storage facilities(15). 
2.9.2. Vaccine vial monitor (VVM) 
VVMs are time-temperature-sensitive labels attached to vaccine vials(45). Before the 
development of the VVM, health workers had little or no means of identifying whether 
vaccine had suffered damage from heat at a point during transportation and/or storage(15). 
Therefore, health workers depended on appropriate storage and transportation of vaccines 
and were trained to discard all vaccines after breaks or suspected breakage in the cold chain. 
In some places, health workers are instructed to discard all vaccine that has been taken to the 
field twice without being used, regardless of whether there was heat exposure or not. Such 
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precautions against possible heat damage result in large amounts of usable vaccine being 
discarded. The VVMs have solved some of these problems. 
2.9.3. Multidose vial policy 
The multidose vial policy (MDVP), was introduced in 1995 and revised in 2000 on the 
basis of data collected on the safety and potency of vaccines recommended for use in 
immunization services by WHO(39). Multidose vials of OPV, PENTA, ATT, hepatitis B, and 
liquid formulations of Hib vaccines from which one or more doses of vaccine have been 
removed during an immunization session may be used in subsequent immunization sessions 
for up to a maximum of 28 days provided that the following conditions are met(39): 
• The expiry date has not passed; 
• The vaccine is stored under appropriate cold chain conditions; 
• The vaccine vial septum has not been submerged in water; 
• Aseptic technique has been used to withdraw all doses; 
• The VVM, if attached, has not reached its discard point 
In Bhutan, the implementation of MDVP gave rise to dramatic decreases in the 
wastage of liquid vaccines. In comparison with baseline data from the districts, wastage 
decreased by 49% for OPV, 27% for DTP, 56% for TT and 24% for HepB vaccine(15). This 
policy does not change the recommendations of handling vaccines and those not concern 
most lyophilized vaccines. For example, for BCG, Measles and yellow fever vaccines, once 
they are reconstituted, vaccines vials must be kept at 2-8ºC and must be discarded at the end 





2.9.4. Earliest-expiry-first-out principle 
In general, when two batches of vaccine are delivered at different times, the second to 
arrive has a later expiry date than the other especially if the vaccines are derived from the 
same source. Therefore, the expiry date must always be checked and the vaccine with the 
shortest shelf-life should be distributed first, even if it arrived last. Therefore, the earliest-
expiry-first out principle is better than the first in first out principle that is commonly known. 
2.9.5. Improved procurement practices 
Improved procurement practices involves better vaccine forecasting with more realistic 
wastage rates in order to prevent the arrival of vaccines in excess(15). This may lead to 
mismanagement of the vaccines and storage in suboptimal conditions. Not only can it 
increase wastage, in areas where vaccine forecast is poor, with small amount of vaccines 
supplied relative to needs, vaccination coverage can be compromised. 
2.9.6. Optimizing immunization session frequency with session size and vial size  
Wastage can be reduced by increasing the size of a vaccination session (number of 
children to be vaccinated at a time). However, this may result in compromising coverage as 
some children vaccination may be postponed to make room for a bigger session some other 
day. This session size has the greatest potential for negatively affecting vaccination coverage 
among all the methods of reducing vaccine wastage(15). Consequently, this option should be 
used with caution and may be more applicable in urban settings where population density is 
much and children can easily be ‘gathered’.  
2.9.7. Prevention of freezing  
With the frequent introduction of new and costly vaccines, that are freeze-sensitive, 
vaccine freezing has become a topic on which national managers seek advice. Vaccine 
freezing is preventable and therefore is treated as unacceptable. All possible measures should 
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be taken to prevent wastage attributable to freezing as exposing vaccines to freezing 
temperatures during storage and transportation may lead to wastage.  
2.9.8. Safe immunization practices  
Safe immunization injection practices should be followed for all vaccines. A new 
sterile syringe and needle should be used for each new dose given, and the correct route and 
dosage must also be observed for each type of vaccine. This greatly reduces vaccine wastage 
therefore, health personnel most be appropriately trained and frequent retrained on safe 
immunization practices.   
2.9.9. Improved vaccine management practices  
There is more and more need for training in vaccine management because of the 
number of changes in vaccines, presentations and global vaccine handling practices over the 
past several years, including the introduction of new and underused vaccines through 
GAVI(15). A need for better vaccine management practices has also been demonstrated by 
high levels of wastage in many countries, a lack of utilization of policies and equipment that 
would reduce vaccine wastage such as MDVP and VVMs, and adverse events attributable at 
least partially to inappropriate vaccine distribution practices(15).  
2.9.10. Prevention of submergence of vials in water  
If vaccines are not well protected, opened vials may be submerged in water from 
melting ice. By definition, these vials are considered contaminated. To prevent this, health 
workers are advised not to get vaccines in direct contact with ice pack. All opened and 
unopened vials must be kept in zip-lock bags in order to prevent any direct contact with 
water. This practice also prevents labels from becoming wet and lost since vials without 





 Study design 
This was a record based analytical study carried out in the Littoral Region of 
Cameroon using the 2016 and 2017 immunization data for children less than 5 years. 
Immunization data from all the 24 health districts making up the region and for the two years 
was included in the study. Health districts in the littoral region are classified as ‘urban’, 
‘semi-urban’ and ‘rural’ based on their remoteness. For this study, the health districts were 
grouped into ‘rural’ and ‘urban’ health districts where the ‘semi-urban’ health districts were 
combined with the ‘urban’ health districts since they lack the peculiar ‘rural’ characteristics.  
 Study setting 
This study was carried out in Cameroon. Cameroon’s health system is divided into ten 
territories called regions which are further divided in to 189 health districts(24). These health 
districts are further divided into health areas. Littoral is one of the regions with the highest 
population density of the ten regions and with 24 of the 189 health districts of the entire 
country. It has 522 health areas.  
The region is headed by the Regional Delegate of Public Health (RDPH) with a unit in 
charge of EPI headed by a public health expert. The health district is headed by a District 
Medical Officer (DMO) who has direct supervision from the RDPH. Out of the 24 health 
districts, 3 are urban, 9 are semi-urban and 12 are rural health districts. Figure 4 show the 




Figure 4. The Littoral region and the other 9 health regions of Cameroon {Source: (45)} 
There are two seasons in the littoral regions; the rainy season and the dry season. The 
Rainy season starts in June and goes through November while the dry season begins in 
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December and goes through May(25). Road networks during the raining seasons are usually 
not in good condition especially in the rural districts. Power failure is almost regularly due to 
the effect of wind current on electric poles. Also, mechanical failures in electrical 
installations are rampant during this season and these failures are worsen by inaccessible road 
even for reparation. Vaccines supply chain is particularly difficult in rural districts during this 
season due to these circumstances(47). Again, with rough roads, chances of accidents are 
high resulting in unopened vial vaccine wastage when health personnel displace themselves 
for outreach vaccination sessions. 
In 2017 for example, the estimated total population of the littoral region was 3693824 
with a total of 95644 live births(48). There are 522 sub districts (or health areas) in the region 















BANGUE 313,369 7,739 7,449 38 Urban 
BOKO 345,039 8,521 8,201 40 Semi urban 
BONASSAMA 417,084 10,300 9,914 35 Semi urban 
CITE DES PALMIERS 313,991 7,754 7,463 36 Semi urban 
DEIDO 587,682 14,513 13,969 51 Urban 
JAPOMA 140,651 3,473 3,343 27 Semi urban 
LOGBABA 225,431 5,567 5,358 26 Urban 
NEW BELL 294,419 7,271 6,998 23 Semi urban 
NYLON 403,474 9,964 9,590 36 Semi urban 
ABO 29,741 936 877 16 Rural 
DIBOMBARI 21,550 678 635 5 Rural 
EDEA 127,898 4,026 3,770 40 Semi urban 
LOUM 52,966 1,667 1,561 11 Rural 
MANJO 37,043 1,166 1,092 13 Rural 
MANOKA 19,572 616 577 5 Rural 
MBANGA 64,636 2,034 1,905 14 Rural 
MELONG 77,058 2,425 2,272 32 Rural 
NDOM 25,715 809 758 15 Rural 
NGAMBE 10,446 329 308 7 Rural 
NJOMBE PENJA 49,133 1,546 1,448 7 Semi urban 
NKONDJOCK 21,353 672 629 8 Rural 
NKONGSAMBA 87,996 2,770 2,594 18 Semi urban 
POUMA 13,045 411 385 10 Rural 
YABASSI 14,532 457 428 9 Rural 
Total 3,693,824 95,644 91,524 522 NA 




 Study Participants 
Study participants were children less than 5 years in the Littoral Region of Cameroon. 
However, the children were not directly involved in the study. All vaccination records from 
1st January 2016 to the 31st December 2017 of children less than 5 years was retrieved and 
analyzed. The vaccines under consideration in this study were Bacille Calmette Guerin 
(BCG), Oral Polio Vaccine (OPV), Inactivated Polio Vaccine (IPV), Diphtheria, Pertussis, 
Tetanus Hepatitis B and Hemophilus influenza type b (PENTA), Pneumococcal Conjugate 
Vaccine (PCV), ROTA, Measles and Rubella (MR), and Yellow fever.   
3.3.1. Inclusion criteria 
Any vaccination record in the Littoral Region of Cameroon between January 1st 2016 
and December 31st 2017 in BCG, OPV, IPV, PENTA, PCV, ROTA, MR and Yellow fever 
was included in the study. 
3.3.2. Exclusion criteria 
Records of other vaccines like Ante Tetanus Toxoids (ATT) and Human Papiloma 
Virus (HPV) were excluded from being used in this study since they are not given to children 
less than 5 years. 
 Data source and data collecting process 
Information regarding number of children vaccinated and number of doses of vaccines 
used was gotten from the immunization data of the Littoral Region of Cameroon. This data 
was obtained with authorization from the ministry of public health of Cameroon. 
To obtain the data, a letter was address to the Central Technical Group (CTG) of 
Expanded Program of Immunization (EPI) requesting the use of the data. upon approval, the 
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data was granted access to, then it was proceeded by cleaning to remove data on other 
vaccines like the HPV and ATT since there were not to be included in the study. 
 Variables and the sources of data 




Table 6. Variables in the study  
Variables Specifications Remark 
Children vaccinated 
Number of children 
vaccinated each month 
 
Used to calculate Vaccine 
Wastage Rate (VWR) 
Vaccine doses 
Doses Received 
Doses received by the health district during the 
month 
Doses in stock 
Doses in the health district at the beginning of each 
month (Left over doses from the previous month) 
Doses remaining (and 
usable)  
Doses left in the health district at the end of the 
month 
Doses used 
Calculated from Doses received and doses 
remaining 
Doses wasted 
Calculated as difference between number of 
children vaccinated and doses used 
Months 




Dry season (1) From December to May Quite Favorable conditions 
Rainy season (1) From June to November Unfavorable conditions  
Health Districts    
Setting  
Rural Areas (12 HD) Poor road and electricity supply  Unfavorable 
Urban Areas (12 HD) 9 ‘semi urban’ and 3 ‘urban’ More favourable 
Vaccines Liquid 
Oral Polio Vaccine 
Wastage relatively easily 
managed through the OPV 
DTP-HepB Hib (PENTA) 






Variables Specifications Remark 
Lyophilized 
BCG Potential for conflict 
between reduction in 
vaccine wastage and MOV 







DTP-HepB Hib (Penta) 
Not very easily 










 Calculation of wastage rate and data analysis 
3.6.1. Calculation of Vaccine coverage and vaccine wastage rate 
The following formulae were used for the following calculations (15): 
i. Vaccination coverage rate  
𝑉𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 𝑟𝑎𝑡𝑒 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝑣𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑒𝑑
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑒𝑙𝑖𝑔𝑖𝑏𝑙𝑒 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛
× 100 
ii. Number of doses used 
𝐷𝑜𝑠𝑒𝑠 𝑢𝑠𝑒𝑑 = 𝐷𝑜𝑠𝑒𝑠 𝑟𝑒𝑐𝑒𝑖𝑣𝑒𝑑 + 𝐷𝑜𝑠𝑒𝑠 𝑖𝑛 𝑠𝑡𝑜𝑐𝑘 − 𝑢𝑠𝑎𝑏𝑙𝑒 𝑑𝑜𝑠𝑒𝑠 𝑟𝑒𝑚𝑎𝑖𝑛𝑖𝑛𝑔 
iii. Number of doses wasted 
𝐷𝑜𝑠𝑒 𝑤𝑎𝑠𝑡𝑒𝑑 = 𝐷𝑜𝑠𝑒𝑠 𝑢𝑠𝑒𝑑 − 𝐶ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝑣𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑒𝑑 
iv. Vaccine Wastage Rate (VWR)  




v. Vaccine Wastage Factor (VWF) 
𝑉𝑎𝑐𝑐𝑖𝑛𝑒 𝑤𝑎𝑠𝑡𝑎𝑔𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 =
100
100 − 𝑉𝑎𝑐𝑐𝑖𝑛𝑒 𝑤𝑎𝑠𝑡𝑎𝑔𝑒 𝑟𝑎𝑡𝑒
 
3.6.2. Data analysis 
The immunization data was entered into a spread sheet. Groupings into seasons, 
urbanization and liquid or lyophilized vaccines was done. Data was analyzed using r version 
3.6.0, where the chi square (χ2) test was applied for finding difference across rural and urban 
health districts and between the dry and the rainy seasons. Graphs of vaccine coverage was 
drawn and compared with that of vaccine wastage to evaluate the relationship between 
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vaccination coverage and vaccine wastage. Vaccine wastage rate was calculated for the 
individual vaccines, liquid and lyophilized vaccines, and oral and injectable vaccines. Level 
of significance will be set at 5% and the 95% confidence interval will be used. 
 Ethical considerations 
Data (vaccination records of the Littoral Region of Cameroon) was provided to the 
researcher with permission from the Ministry of Public Health, Cameroon and all of the data 
was processed with anonymity, and only to be used on researcher’s personal computer and only 
for the purposes of this study 
No personal information was involved in this study. Even names of health district were 
not used. Instead, they will be classified as ‘rural’ and ‘urban’ 
Ethical clearance was sorted from Yonsei University Health System Institutional Review 
Board and administrative clearance from the Yonsei University, Graduate School of Public 
Health, South Korea. 
 Limitations of the study 
Like most scientific studies, this study has some limitations: 
The study uses secondary data where the researcher was not directly involved in 
collecting the data. Inherent to secondary data, the accuracy of the result of the study depends 
on the accuracy with which the data was collected in the first place.   
With the MDVP, an opened vail can still be used for up 28 days. This means that the 
doses inside an opened vial may still be usable. However, at the end of the month, only 
unopened vials are reported as doses remaining. Because data does not account for doses in 
opened vials remaining at the end of the month, there are considered as used. This involved 
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only liquid vaccines. These doses are however used and accounted for in the following 
month. Using data for the entire year reduces the effects of these ‘left over open vial doses’ 
on calculations of vaccine wastage. 
Wastage rates and wastage factors calculated from this data may not reflect rates at 





The data shows that there was a reduction in population from in 2017 compared to 2016. For 
example, in 2016, 133,389 children were targeted for BCG in the urban districts but only 
83,444 were targeted in the urban districts in 2017 as presented in Table 7. In both years, 
more children were vaccinated in BCG, MR and Yellow in the dry season compared to the 
rainy season. For example, in 2016, 46528 children were vaccinated in BCG but only 41,513 
were vaccinated in the rainy season. On the contrary, Lesser number of children were 
vaccinated in the dry season with the liquid vaccines in both 2016 and 2017. For instance, 
only 75,031 children were vaccinated with Rota vaccine during the dry season but 86,599 
children were vaccinated with the same vaccine in 2017 in the rainy season (Table 7).  
A total of 2851527 doses of vaccines were used in 2016 and 2017 in the Littoral 
Region of Cameroon to vaccinate 2640077 children with BCG, OPV, IPV, PENTA, PCV, 
ROTA, MR and Yellow fever. Out of these, 1,472,156 doses where used in 2016 to vaccinate 
1,369,676 children and 1,379,371 doses where used to vaccinate 1,270,401 children in 2017. 
The vaccine wastage rate (VWR) for both years combined was highest in BCG and stood at 
32.19% seconded by Measle and Rubella (MR) vaccine (19.05%) and then Yellow fever and 
IPV having 18.34% and 17.87% respectively. There were negative wastage rates in PCV and 
ROTA throughout 2016 and 2017. Like the wastage rate, vaccine wastage factor (VWF) was 
also highest in BCG followed by MR, then IPV and their values stood at 1.0031, 1.0018, 
1.0018 and 1.0018 respectively as shown in Table 8. 
Comparing vaccine wastage between 2016 and 2017, the trend is exactly the same 
across vaccines in both years; BCG has the highest vaccine wastage rate, followed by MR 
vaccine, yellow fever vaccine and inactivate polio vaccine (IPV). Also, for both years, 
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Pneumococcal Conjugate Vaccine (PCV) and Rota vaccines had negative wastage rates, 
however, the VWR for 2017 was slightly greater than that in 2016 for all the vaccines except 









Table 8. Wastage rate and wastage factor for different vaccines in the Littoral region in between 2016 and 2017 
Vaccine 

























BCG 88,041 128,233 31.34% 1.0031 84,956 126,892 33.05% 1.0033 172,997 255,125 32.19% 1.0032 
OPV 347,083 360,238 3.65% 1.0004 327,576 344,233 4.84% 1.0005 674,659 704,471 4.23% 1.0004 
IPV 84,196 102,329 17.72% 1.0018 73,460 89,621 18.03% 1.0018 157,656 191,950 17.87% 1.0018 
PENTA 259,277 265,547 2.36% 1.0002 241,162 253,707 4.94% 1.0005 500,439 519,254 3.62% 1.0004 
PCV 259,079 251,142 -3.16% 0.9997 242,642 233,048 -4.12% 0.9996 501,721 484,190 -3.62% 0.9996 
Rota 168,835 165,226 -2.18% 0.9998 161,630 159,736 -1.19% 0.9999 330,465 324,962 -1.69% 0.9998 
MR  81,642 100,052 18.40% 1.0018 66,533 82,990 19.83% 1.0020 148,175 183,042 19.05% 1.0019 
Yellow 
fever 
81,523 99,389 17.98% 1.0018 72,442 89,144 18.74% 1.0019 153,965 188,533 18.34% 1.0018 






Figure 5. Vaccine wastage rates for various vaccines comparing 2016 and 2017 
 Relationship between immunization coverage and vaccine wastage 
In general terms, in both 2016 and 2017, the vaccination coverages start high in 
January and remarkably decreases in February before increasing again. From October, 
vaccine coverage starts a progressive decline trend till December except for BCG that 
interrupts this trend by increasing in December. However, the most remarkable decline is 
exhibited by coverage in MR vaccine and BCG as can be seen in Figure 6 and 7.  
Like vaccination coverage, VWR for the various vaccines exhibit the same trend but in 
the reverse order. Vaccine wastage tern to increase at each time vaccine coverage decreases 
except for 2016 (Figure 6) as from October where both vaccine coverage and vaccine 

























Figure 6. Variations between vaccine coverage and vaccine wastage for BCG, IPV and 
Measles in 2016 
 
Figure 7. Variations between vaccine coverage and vaccine wastage for BCG, IPV and 
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 Urbanization and effect on vaccine wastage rate 
In both 2016 (Figure 8) and 2017 (Figure 9), vaccine wastage rates were consistently 
higher in all the vaccines in the rural health districts compared to the urban health districts. 
And again, vaccine wastage rates were negative for PCV and Rota vaccines in both rural and 
urban health districts in 2016 and 2017 except the VWR for Rota vaccine that was positive in 
2017 and stood at 0.89% compared to -1.51% in the urban districts. 
 



















Figure 9. Vaccine wastage comparing rural and urban health districts in 2017 
As presented in Table 9, wastage rates for all vaccines except PCV and Rota vaccines 
were statistically significantly different at alpha (α) = 5%, between rural and urban health 
districts in the littoral region in 2016 and 2017 with p-values far less than 0.05. In 2016, 
VWR for PCV and Rota vaccines were not significantly different, the p-values 0.085i and 
0.7411 respectively. In 2017, the VWR for Rota joined the others to be statistically 
significant, leaving just that of PCV to remain insignificant at α of 0.005 with a p-value of 
0.0215. 
4.2.1. Urbanization and Vaccine wastage factor 
VWF were distinctively different in BCG, IPV, MR and Yellow fever between urban 
and rural health districts with the rural district having higher rates. The pattern remained the 































BCG OPV IPV PENTA PCV Rota MMR Yellow fever
2016 (Urban) 2016 (Rural) 2017 (Urban) 2017 (Rural)
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Table 9. Vaccine wastage rates for various vaccines comparing rural and urban health districts 
Vaccine 
2016 2017 


















χ2 p value 
BCG 76,912 108,017 11,129 20,216 410.93 <0.0001 74,408 107,754 10,548 19,138 300.01 <0.0001 
OPV 298,562 307,052 48,521 53,186 88.29 <0.0001 285,696 298,535 41,880 45,698 35.58 <0.0001 
IPV 72,580 86,051 11,616 16,278 161.70 <0.0001 64,471 77,052 8,989 12,569 112.35 <0.0001 
PENTA 221,968 225,482 37,309 40,065 50.81 <0.0001 209,745 218,045 31,417 35,662 111.64 <0.0001 
PCV 221,762 214,541 37,317 36,601 2.97 0.0851* 211,082 202,505 31,560 30,543 1.02 0.3127* 
Rota 144,832 141,803 24,003 23,423 0.11 0.7411* 140,414 138,329 21,216 21,407 5.26 0.0215 
MR 70,388 84,489 11,254 15,563 111.85 <0.0001 57,970 70,639 8,563 12,351 124.12 <0.0001 
Yellow 
fever 











4.2.2. Vaccine categories and wastage 
Categorizing vaccines according to their route of administration and their form of 
preservation, rural settings had clearly higher wastage rates compared to urban districts. 
VWR for lyophilized vaccines peaked in both the rural and urban health districts. Comparing 
vaccine wastages for the categories of vaccines between 2016 and 2017, the wastage rates 
were clearly higher in 2017 than in 2016 as presented in Figure 11.   
 
Figure 11. Vaccine wastage between rural and urban health districts comparing 2016 and 2017 
In both years, vaccines administered orally were statistically significantly different 
between rural and urban health districts as well as vaccines administered parenterally with p-
values far <0.0001 at (α) = 5%.   Also, the wastage rate of liquid and lyophilized vaccines 
also statistically significantly differed at the 95% confidence level between urban and rural 






























































 Effect of season on vaccine wastage rate 
In 2016, more vaccines were wasted during the rainy season in the lyophilized 
vaccines (BCG, Measles and Yellow fever) whereas the liquid vaccines were more wasted in 
the dry season than in the rainy season as presented in Figure 12. In 2017 however, the dry 
season had higher vaccine wastage rates compared to the rainy season in all the vaccines. The 
greatest difference occurred with IPV where the dry season had more than twice as higher 
wastage compared to the rainy season which were 25.15% and 12.16% respectively. 
Interestingly the wastage rate for OPV during the raining season in 2017 was close to zero 
(0.28%) as shown in Figure 13. Again, PCV and Rota had negative wastage rates in both 
seasons and in both years. 
 
Figure 12. Vaccine wastage comparing the dry and the rainy season in 2016 







Figure 13. Vaccine wastage comparing the dry and the rainy season in 2017 
 
 
Figure 14. Vaccine wastage comparing 2016 and 2017 between the dry and the rainy seasons 
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Except for the single dose vaccines (Rota and PCV) and only in 2016, the wastage rate 
of all other vaccines was statistically significantly different between the rainy and the dry 
season at the 95% confidence level with p value far less than 0.05. As presented in Table 11, 
wastage rate for the single dose vaccines were not statistically significantly differently 
between the dry and the rainy season in 2016 at a 5% precision level with a p value of 0.2402 
and 0.6175 for PCV and Rota respectively. In 2017 however, even the wastage of these 
single dose vaccines were statistically significantly different between the dry and the rainy 
season at α of 0.05.   
4.3.1. Vaccine wastage factor and seasons  
Vaccine wastage factor was distinctively different between the dry and the rainy 
season in 2017 with the dry season having higher wastage factor. In 2016 however, VWF was 
higher in during the dry season for all of the liquid vaccines (OPV, IPV, PENTA, PCV and 
Rota). In all the lyophilized vaccines, VWF was higher during the rainy season in 2016 as 
shown in Figure 15 
 







BCG OPV IPV PENTA PCV Rota MMR Yellow fever
2016 (Dry season) 2016 (Rainy season)
2017 (Dry season) 2017 (Rainy season)
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4.3.2. Vaccine categories and wastage 
Classifying vaccines into their form of preservation (liquid and lyophilized form) and 
also into their route of administration, during the dry season, the wastage rates in 2017 were 
greater than those of 2016 in all categories of vaccines as presented in Figure 14. However, in 
the rainy season, wastage rates for all the categories of vaccines were higher in 2016 
compared to those in 2017. 
Comparing vaccine wastage rate according to the route of administration between the 
dry and the rainy season, vaccines administered orally were statistically significantly 
different between the dry and the rainy seasons in 2016 and in 2017. There was a statistically 
significant difference in vaccine wastage in vaccine administered by injection between the 
dry and the rainy season in 2017 (p-values far <0.0001) but not in 2016 (p-value 0.7633).   
Also, the wastage rate of liquid and lyophilized vaccines were statistically significantly 
different at the 95% confidence level between the dry and the rainy season in both 2016 and 
2017 as presented in table 12. 
59 
 
Table 11. Statistical differences in vaccine wastage comparing the dry and the rainy seasons 
Vaccine 
2016 2017 


















χ2 p value 
BCG 46,528 65,347 41,513 62,886 74.48 <0.0001 46,621 72,830 38,335 54,062 131.16 <0.0001 
OPV 169,175 177,408 177,908 182,830 18.05 <0.0001 157,827 174,001 169,749 170,232 376.18 <0.0001 
IPV 39,058 48,331 45,138 53,998 13.11 0.0003 30,332 40,522 43,128 49,099 252.87 <0.0001 
PENTA 123,095 126,904 136,182 138,643 5.15 0.0232 111,558 122,948 129,604 130,759 240.39 <0.0001 
PCV 122,782 119,434 136,297 131,708 1.38 0.2402* 111,502 109,070 131,140 123,978 34.36 <0.0001 
Rota 80,297 78,437 88,538 86,789 0.25 0.6175* 75,031 74,839 86,599 84,897 5.96 0.0147 
MMR 42,743 51,316 38,899 48,736 20.37 <0.0001 37,778 49,033 28,755 33,957 80.28 <0.0001 
Yellow 
fever 











V. Discussion  
 
Vaccination is strongly recommended by the medical community for protection against 
diseases especially childhood diseases(1). To achieve full effect of vaccination in the 
population, vaccination coverage must high enough. Vaccine wastage make vaccines less 
available for use especially in remote areas where access to the central vaccine storage 
facility is difficult. Because vaccination coverage must not be compromised by actions to 
reduced vaccine wastage(15), vaccine needs of a population must be calculated taking into 
account vaccine wastage rate. Therefore, vaccine wastage should to be continuously 
monitored at all levels. The World Health Organization has also projected vaccine wastage 
rate in order to help in calculating vaccine needs(29) in cases where actual vaccine wastage is 
not known. According to WHO projected vaccine wastage rate is expected to be 50% for 
BCG, 10% for OPV, 25% for 10-20 dose vials lyophilized vaccines 15% for 10-20 dose 
liquid vaccines and 5% for single dose vaccines. In 2016 and 2017, the targeted wastage rate 
for the Cameroon’s EPI was slightly different from the projected wastage rates by WHO(28). 
Vaccine wastage was highest in lyophilized vaccines. That is BCG, 32.19%, MMR, 
19.05% and Yellow fever, 18.34%. This goes in line with a study in Gambia(11) that also 
saw the wastage rates of lyophilized vaccines higher than all the other vaccines.  In 
comparison with a study in Bangladesh(50), the wastage rates here are much more smaller 
probably because this study uses administrative data since there are always quality issues 
with administrative data because the purpose for which the data was collected is usually 
different(51,52). Closely following the wastage rates for lyophilized vaccines is that of IPV 
which was 17.87%. IPV is a liquid 10 dose vaccine whose wastage rate is expected not to be 
different from that of PENTA. However, it was very high almost reaching the level of 
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lyophilized vaccines. IVP was introduced in to EPI in the Littoral region in June 2015(48) 
and vaccine wastage is expected to increase several fold with the introduction of newer 
vaccines(53) Its management was probably still new to health workers. Our data also 
supports existing evidence that wastage rates are low for vaccines that follow the MDVP as 
in a study in the North West Region of Cameroon(42), and in Bangladesh(50).  
Relationship between immunization coverage and vaccine wastage 
Vaccine wastage cannot be completely prevented in vaccination it can only be 
minimized to an acceptable level. It is not very possible to advocate a universally acceptable 
vaccine wastage level since acceptable wastage levels vary between program in the light of 
experience and the analysis of local situations(15). The relationship between vaccine wastage 
rate and immunization coverage is the key to deciding whether wastage is really high or not. 
If both trends are analyzed over a period of time, vaccine wastage can be assessed to be 
acceptable or not. 
Throughout 2016 and 2017, and except for the period between October and November 
2016, vaccine wastage has been having an antagonistic relationship with vaccination 
coverage. That is, whenever vaccine coverage increases, vaccine wastage decreases and vice 
versa.  If the vaccines are used to vaccinate children, vaccine wastage should decrease with 
increase in vaccination coverage. This is case with most of the periods between 2016 and 
2017. However, there exist other periods where vaccine wastage increases as vaccination 
coverage decreases. These periods include June 2017 (for BCG and MR), from September to 
December 2017 for MR and IPV, January and October 2017 for BCG. Also, May 2016 for 
BCG. The implication is that vaccination coverage didn’t decrease because of lack of 
vaccines but because of its mismanagement or low coverage led to poor vaccine 
management. This explainable since especially in the rural areas, left over vaccines taken to 
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the outreach sites may not get back to the cold chain in their optimal conditions(54) for it to 
be stored again.   
Between October and November 2016, the wastage for all the vaccines decreased as 
the coverage also decreased. This situation can occur when vaccine are not available for 
vaccination or when strong attachments meant to reduce vaccine wastage also compromises 
vaccination coverage(8) like refusing to open up a 10 dose vaccine when there is only one 
target for vaccination. The first case is the most likely cause in this case as there was no BCG 
even at the central vaccine storage facility in Yaoundé at that time. Lack of a particular 
vaccine has a demotivating effect on the health care worker in organizing a(n) vaccination 
(outreach) session as they will need to reorganize such a vaccination again when the other is 
available. Also, if parents are aware that there is a vaccine that is lacking, they are 
demotivated to come for a vaccination given that they will have to come again some other 
time in future to complete the vaccination. The months of February and November are 
peculiar in that vaccination coverage during these two years always decreased and vaccine 
wastage increased.  
Urbanization and effect on vaccine wastage rate 
The MVDP stipulates that a vial may be used for up 28 days after it has been opened 
provided the storage conditions are favourable(39). Therefore, vaccine wastages are expected 
to be low in vaccines that follow these OPV(55). Unfortunately, not all vaccines follow this 
policy. For BCG, MR and Yellow fever, their usage is limited to only six hours after 
reconstitution after which they must be discarded hence unavoidable vaccine wastage(56). It 
is therefore not surprising to see that the wastage rates of BCG, MR and yellow fever 
vaccines were higher than the liquid vaccines in both rural and urban health districts.  
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In areas where the population spaciously distributed, or small, like in rural areas, not 
only are children less likely to be fully immunized or go unimmunized(57), vaccine wastage is 
expected to be high(55) especially for vaccines that don’t follow the MDVP. It is the case with 
the littoral region where over the two years, rural districts had higher vaccine wastage rates 
compared to urban districts. In rural districts, most of the vaccination strategy employed is 
outreach strategy and usually vials taken out to this strategy don’t go back to the vaccine 
storage facility of the health facility if the VVMs are not in place. They have to be discarded. 
The possibility of accidents occurring in the rural areas leading unopened vial breakage is more 
than urban areas given that outreach strategies are the most practiced. Again, in terms of 
personnel rural areas are more likely to have less trained personnel that urban areas(55), all 
these accounting for the elevated wastage rates in rural districts compared to in urban districts. 
Educational status of persons in rural health districts are relatively low compared to urban 
duelers.  
The possibility of not fully understanding the importance of vaccination and 
consequently not respecting vaccination appointment in person with low education level is not 
rule out(30). This will lead to upon vial vaccine wastage especially in lyophilized vaccines.  
Cold chain stability is particularly challenging in rural health districts with the possibility of 
changing vaccines from one cold chain facility to another. This exposes the vaccines to 
alternating temperatures that may result in damage. This finding does not ties with that of  Usuf 
et al in 2018(11) who didn’t find any significant difference in vaccine wastage of any kind 
between rural and urban areas in the Gambia probably because they used few health facilities 
in both areas. Vial presentation also has an influence on vaccine wastage. Single dose vaccines 
are less likely to be subjected to vaccine wastage(15) compared to multi-dose vial vaccines, 
reasons for the statistically insignificant differences between rural and urban health districts in 
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Rota and PCV. However, because of the peculiarities in rural districts, even single dose vaccine 
wastage rates are higher than that for urban health districts.  
The trend in vaccine wastage remained the same in 2016 and 2017. However, more 
vaccines were wasted in 2017 than in 2016. There was a revision of the population in the 
Littoral region in 2017 that lead to a reduction in the overall total population and 
consequently a reduction in the target population. Vaccine supplies had to follow the 
reduction; however, this might not have been the case as adapting to the ‘new population’ 
was a challenge to the health personnel.    
Vaccine wastage and type of vaccine 
Oral vaccines are easy to administer and less prone to wastage compared to injectable 
vaccines (no dead space in the syringe involved), making oral vaccines to have lesser wastage 
rates compared to injectable vaccines. With Lyophilized vaccines, their wasted rate is higher 
compared to liquid vaccines because they (lyophilized vaccines) have to be discarded 6 hours 
after reconstruction or at the end of the vaccination session, whichever comes first(15). This 
is not the case with most liquid vaccines; they are used according to the MDVP. 
BCG, MR and yellow fever make up the list of lyophilized vaccines and among them, 
BCG has the highest wastage rate because the BCG used in Cameroon is a 20-dose vial 
vaccine. The possibility of ‘gathering’ many children in one vaccination session so as to 
reduce vaccine wastage is low and the situation is much worse in rural areas. This makes 
BCG the vaccine with the highest wastage rate. Nearby health facilities with small 
vaccination session size usually plan vaccination sessions on the same day so as to share 




Effect of season on vaccine wastage rate 
There are two major seasons in Cameroon; the rainy season and the dry season. 
Though the dry season is dusty especially in rural areas, it is more favourable in terms of 
weather and road conditions. Electricity is somewhat more stable in the dry season compared 
to the rainy season. In the rainy season however, the reverse is true. During the rainy season 
due to poor weather, parents may be constraint to miss their vaccination appointments and 
this will increase the wastage rate of vaccine that don’t follow the open vial policy (BCG, 
MMR and Yellow fever). Probably why in 2016, vaccine wastage for BCG, MMR and 
yellow fever (Lyophilized vaccines) were higher during the rainy season. However, the liquid 
vaccines’ wastage rates were higher in the dry season compared to the rainy season which is 
quite expected. In 2017, the wastage rate for all the vaccines were unexpectedly higher in the 
dry season where conditions are much more favourable than in the rainy season.  
Policy implications 
Vaccine wastage is expected in all the program, all localities and at all levels. Though 
all measures should be taken to reduce vaccine wastage, the one that should not be influenced 
negatively is vaccination coverage. There should be an acceptable limit of vaccine wastage 
which might differ from location to location depending on many factors like urban and rural 
setting, immunization coverage and even seasons of the year. 
Since vaccine wastage is not completely avoidable and that vaccination coverage must 
not be affected by efforts to reduced vaccine wastage policy needs to be enforced to 
continuously monitor vaccine wastage and used it estimating vaccine needs of the population. 
In as much as higher wastage rate are acceptable to increased vaccine coverage in a low 
vaccine coverage setting, efforts to reduce vaccine wastage should not be undermined as it 
redirects already scarce funds to other needed aspects in health and it is useful as a program 
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monitoring tool to improve program quality and to increase the efficiency of the program. 
Vaccine wastage could be reduced by continued training of workers involved in 
immunization, actual monitoring of the vaccination session, frequent supportive supervision. 
Innovative approaches to reduce vaccine wastage 
Perhaps, the most innovative approach to vaccine management is the controlled 
temperature chain (CTC) which allows vaccines to be kept at temperatures outside of the 
traditional cold chain of +2°C to +8°C for a period of time under monitored and controlled 
conditions, as appropriate to the stability of the antigen(58). This typically involves a single 
excursion of the vaccine into ambient temperatures but never exceeding +40°C and for 
duration of a specific number of days, just before administration. 
The following programmatic criteria for a vaccine to be labelled for and used in a CTC 
has been established by WHO(58): 
a) The vaccine should be used only in a vaccination campaign or special strategy 
setting. CTC is not currently recommended for immunization through routine 
delivery. 
b) The vaccine must be able to tolerate ambient temperatures of at least +40°C for a 
minimum of three days and should be accompanied by: 
a. a vaccine vial monitor (VVM) on each vial, and 
b. a peak threshold indicator in each vaccine carrier. 
c) The vaccine must be licensed for use in a CTC by the relevant regulatory authorities, 
with a label that specifies the conditions. 
However, for now, not all vaccines are involved and they can only be used during 




Vaccine wastage is not completely avoidable and vaccination coverage must not be 
compromised by actions to reduced vaccine wastage. Therefore, vaccine needs of a 
population must be calculated taking into account vaccine wastage rate. Analyzing vaccine 
wastage in relation with immunization coverage is key to deciding whether wastage is really 
high or not. In the Littoral region of Cameroon, the relationship between immunization 
coverage and vaccine wastage is mostly inverse; vaccine wastage decreasing as immunization 
coverage increases and vice versa. 
Although urban health areas have their own challenges to vaccination activities which 
are mostly linked to low quality of monitoring and tracking, factors such as parent’s objection 
or disagreement, concerns about safety of vaccines, walking distances to health facilities and 
waiting time in the health facilities, health worker density and logistics availability are 
usually more prevalent in rural than urban settings. With these peculiar characteristics in rural 
health districts, vaccine wastage tern to be higher than in urban heath districts.  
The dry season present much more favourable conditions for vaccination activities in 
especially in rural health districts. However, apart from vaccine wastage rate for lyophilized 
vaccines that were expectedly higher in the rainy season in 2016 only, vaccine wastage rates 
are surprisingly higher in the dry season than in the rainy.   
The MDVP has come to relieve some vaccines (especially liquid vaccines) of some 
wastages. However, the problem still remains with lyophilized vaccines which cannot follow 
the MDVP. Practical efforts to reduce wastage rate includes increasing the vaccination 
session size but this usually may lead to miss opportunity to vaccinate are so are discouraged. 
Outreach vaccination strategies help resolve this. 
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Effective and efficient management and utilization of vaccines enhances regular supply 
of the vaccines and is essential for vaccine security while simultaneously keeping a check on 
the program costs. With the diverse settings in the Littoral region of Cameroon, a better 
vaccine forecasting with more realistic wastage rates in order to prevent the arrival of 
vaccines in excess or in deficit is indicated. 
This study used administrative vaccination data for the littoral region in 2016 and 
2017. Thought it is official data, it is secondary data that wasn’t collected primary for the 
purpose of this study so it may not articulately portray the problem as it is in real situation. 
Therefore, future study should be designed to collect data primarily for the kind of study. 
Also, differences in vaccine wastage between the dry season and the rainy season should be a 
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